Not Yet RecruitingPhase 2
NCT07468916Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and…
This phase II trial tests the safety, best dose, and effectiveness of ropeginterferon alfa-2b for the treatment of patients with myelodysplastic syndrome/myelop…
United States35 participantsStarted 2026-09-29Updated 2026-05-06 Treatment: Biospecimen Collection, Bone Marrow Aspiration
TerminatedPhase 1
NCT04637009A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms
This is a Phase 1, 2-part, open-label, multicenter, first-in-human (FIH) study to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD), and prelimina…
United States, Canada20 participantsStarted 2020-12-21Updated 2024-08-02 Treatment: TAS1553